End-to-End Biopharma QC with Genedata Selector: Enabling Scalable, GxP-Compliant NGS
This infographic highlights the critical quality control (QC) challenges faced across modern biopharmaceutical production and demonstrates how in-house next-generation sequencing (NGS), powered by Genedata Selector®, enables robust, scalable, and GxP compliant QC workflows.
Outlined in the infographic, the core topics for operationalizing NGS in GxP-compliant QC environments include:
- Key risks that must be monitored throughout development and manufacturing
- Comprehensive QC coverage across the workflow, from raw materials QC to drug product and lot testing
- Benefits of in-house NGS with Genedata Selector
- Enabling GxP-compliant QC at scale
Read the full article to find out more.
